P

PVLA

Palvella Therapeutics Inc

157.24

Jul 17 • 03:59PM ET +9.47 (6.41%)

160.00

Aftermarket • 07:51PM ET +2.76 (1.76%)

Healthcare Biotechnology USA Mid NASD

Peers: KYMR MANE ORKA RYTM KRYS NUVL BMRN INCY AXSM NBIX

| Held by: XBI VTI IWM VXF IWO VTWO VHT VFMO LFSC SBIO

Scroll to Statements

Index	RUT
Market Cap	2.26B
Enterprise Value	2.01B
Income	-49.30M
Sales	0.00M
Book/sh	16.23
Cash/sh	18.26
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	29
IPO	Jan 02, 2015

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	9.69
P/C	8.61
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	28.88
Current Ratio	28.88
Debt/Eq	0.09
LT Debt/Eq	0.09
Option/Short	Yes / Yes

EPS (ttm)	-4.17
EPS next Y	-6.43
EPS next Q	-1.16
EPS this Y	-48.88%
EPS next Y	-16.45%
EPS next 5Y	12.81%
EPS past 3/5Y	53.08% 41.62%
Sales past 3/5Y	- -
EPS Y/Y TTM	66.94%
Sales Y/Y TTM	-
EPS Q/Q	-62.12%
Sales Q/Q	-
Earnings	May 07 BMO
EPS/Sales Surpr.	-28.34% -

Insider Own	29.40%
Insider Trans	-0.55%
Inst Own	82.77%
Inst Trans	33.21%
ROA	-28.73%
ROE	-34.25%
ROIC	-19.52%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	10.84%
SMA50	25.71%
SMA200	48.51%
Trades

Shs Outstand	14.31M
Shs Float	10.13M
Short Float	23.36%
Short Ratio	9.07
Short Interest	2.37M
52W High	161.38 -2.57%
52W Low	28.19 457.75%
Volatility	6.39% 7.01%
ATR (14)	9.27
RSI (14)	64.33
Beta	-0.17
Rel Volume	0.99
Avg Volume	260.97K
Volume	258,337

Perf Week	8.62%
Perf Month	42.79%
Perf Quarter	26.62%
Perf Half Y	49.33%
Perf YTD	50.22%
Perf Year	403.49%
Perf 3Y	949.95%
Perf 5Y	-43.19%
Perf 10Y	14.94%
Recom	1.00
Target Price	229.00
Prev Close	147.77
Price	157.24
Change	6.41%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)